Fluoxetine After Weight Restoration in Anorexia Nervosa—Correction

Incorrect Data: In the Original Contribution entitled “Fluoxetine After Weight Restoration in Anorexia Nervosa” published in the June 14, 2006, issue of JAMA (2006;295:2605-2612), the boxes in Figure 1 that stated the reasons for premature termination for participants taking fluoxetine and placebo were switched. In the box describing reasons for termination for participants taking the placebo, “Suicide Attempt” was incorrectly substituted for “Clinical Deterioration.” In Tables 1, 3, and the Measures section, The Yale Brown Cornell Obsessive Compulsive Scale for Eating Disorders should have been termed the Yale-Brown-Cornell Eating Disorder Scale and the Eating Disorders Inventory should have been termed the Eating Disorder Inventory. In the Table 2 footnotes, the χ² value after “§Proportion of patients with outcome status of full recovery, good, or fair vs poor with fluoxetine vs placebo” should have been χ² = 1.005. In Table 3, the random-effects regression for the fluoxetine group for the Eating Disorder Inventory bulimia subscale should have been 0.11 rather than −0.11. In the last paragraph of the article, the references 24,25 after “psychological treatments” should have been numbered 24 and references 26,27 after “olanzapine” should have been numbered 26. None of these corrections affect the conclusions in the article.